Galectin Therapeutics
GALT
GALT
45 hedge funds and large institutions have $8.34M invested in Galectin Therapeutics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 5 reducing their positions, and 2 closing their positions.
Holders
45
Holders Change
+2
Holders Change %
+4.65%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
17
Reduced
5
Closed
2
Calls
$784K
Puts
$272K
Net Calls
+$512K
Net Calls Change
+$449K
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.7M |
| 2 |
2
Charles Schwab
San Francisco,
California
|
$351K |
| 3 |
3
BlackRock
New York
|
$298K |
| 4 |
4
Morgan Stanley
New York
|
$206K |
| 5 |
DADC
5
D.A. Davidson & Co
Great Falls,
Montana
|
$1.84M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
RFM
51
Royal Fund Management
Lady Lake,
Florida
| $0 | 7 | – | – |
|
52
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|